Robert B Bazemore

CIK 1620152 · President & CEO · last filed 2026-05-26

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$834.6K

Companies

7

Total Filings

45

Lifetime Open-Market Net

-$934.5K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
NUVB Director $4.92 $0 1 2026-05-26
AKTX Director 44,642 $13.40 $598.2K $0 4 2025-12-18
ARDX Director 41,551 $5.69 $236.4K $0 10 2025-06-23
Nuvation Bio Inc. (NUVB.WS) Delisted Director 5,000 $0.01 $26 $49.9K 8 2025-05-23
Epizyme, Inc. (EPZM) Delisted President & CEO 322,626 $1.47 $474.3K -$984.4K 16 2021-03-29
Neon Therapeutics, Inc. (NTGN) Delisted Director $0 3 2020-05-06
SYNAGEVA BIOPHARMA CORP (GEVA) Delisted Chief Operating Officer 0 $0 3 2015-06-23

Recent Filings · Page 5 of 5

45 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2016-06-06 ARDX Grant (A) $0 EDGAR
2016-02-10 Epizyme, Inc. (EPZM) Delisted Grant (A) $0 EDGAR
2015-06-23 SYNAGEVA BIOPHARMA CORP (GEVA) Delisted Disp (D) −35,000 $0 EDGAR
2015-06-09 SYNAGEVA BIOPHARMA CORP (GEVA) Delisted Grant (A) +5,000 $0 EDGAR
2014-09-25 SYNAGEVA BIOPHARMA CORP (GEVA) Delisted Grant (A) +30,000 $0 EDGAR
Showing 4145 of 45
Page 5 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.